Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2924037 | 0.90 | TSHR (0.44) | TSHRPPARG | |
| 3-(3-(3-(4-Hydroxyphenyl)Propyl)-4,5-Dihydroisoxazol-5-Yl)Phenol (Enantiomeric Mix) SCHEMBL2924055 | 0.88 | CYP19A1 (0.40) | PPARG | |
| SCHEMBL2924437 | 0.85 | TSHR (0.46) | TSHRPPARG | |
| SCHEMBL2914616 | 0.83 | PTPN1 (0.49) | TSHRPPARG | |
| SCHEMBL2923049 | 0.81 | TSHR (0.46) | TSHRPPARG | |
| 5-Benzyl-3-[3-(4-Hydroxy-Phenyl)-Propyl]-4,5-Dihydroisoxazole (Enantiomeric Mix) SCHEMBL2923872 | 0.80 | — | — | |
| 5-(4-Hydroxy-Benzyl)-3-[3-(4-Hydroxy-Phenyl)-Propyl]-4,5-Dihydro-Isoxazole (Enantiomeric Mix) SCHEMBL2920888 | 0.76 | CALM1 (0.38) | — | |
| SCHEMBL5994321 | 0.75 | TSHR (0.53) | TSHRPPARG | |
| SCHEMBL2919709 | 0.73 | TSHR (0.47) | TSHRPPARG | |
| SCHEMBL2923074 | 0.73 | CYP19A1 (0.42) | PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100267784-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | PULKKINEN JUHA | 2010-10-21 | — | — | US | claimed |
| US-20100267784-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | PULKKINEN JUHA | 2010-10-21 | — | — | US | disclosed |
| US-20100267784-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | PULKKINEN JUHA | 2010-10-21 | — | — | US | disclosed |
| US-20100267784-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | PULKKINEN JUHA | 2010-10-21 | — | — | US | disclosed |
| EP-2222653-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | Pulkkinen, Juha (FI) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009066009-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | PULKKINEN JUHA (FI) | 2009-05-28 | — | — | WO | disclosed |
| WO-2009066009-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | PULKKINEN JUHA (FI) | 2009-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267784-A1 | NOVEL 4,5-DIHYDROISOXAZOLES WITH ESTROGENIC ACTIVITY | ESR2, GPER1, CYP19A1 | TSHR 746/4885PPARG 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.